Form 8-K - Current report:
SEC Accession No. 0001493152-24-002048
Filing Date
2024-01-11
Accepted
2024-01-11 15:25:29
Documents
15
Period of Report
2024-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41121
2 ex10-1.htm EX-10.1 1844
3 ex10-1_001.jpg GRAPHIC 350535
4 ex10-1_002.jpg GRAPHIC 58375
  Complete submission text file 0001493152-24-002048.txt   775288

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sigy-20240109.xsd EX-101.SCH 3042
6 XBRL LABEL FILE sigy-20240109_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE sigy-20240109_pre.xml EX-101.PRE 22377
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3051
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 24529126
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)